Galectin Therapeutics (GALT) Stock Price, Quote, News & History | Benzinga

SPY775.01+0.70%QQQ755.86+0.84%BTC/USD85,708.30−0.93%DIA512.24+0.22%GLD379.64−0.13%TLT77.13−0.46%

Galectin Therapeutics Inc (GALT) Stock Price, Quote, News & History

GALTNASDAQ

Trade with Public

Trade with Public

$3.73

-0.17-4.36%

Last update: Oct 5, 3:47 PM

$3.85

-0.05-1.28%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.84

Close

-

Volume / Avg.

217.30K / 399.44K

Day Range

$3.64 - $3.90

52 Wk Range

2.03 - 7.13

Market Cap

$376.17M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

12.13%

Days to Cover

25.16

Recent Galectin Therapeutics Inc News

Goldman Sachs Posts Upbeat Q2 Earnings, Joins SK Hynix, Tower Semiconductor And Other Big Stocks Moving Higher On Tuesday

Goldman Sachs (NYSE: GS) shares surged 6.9% after beating earnings estimates. Other big gainers include PHOE, SKHY, GALT, AXTI, FCEL, AAOI, CHRN, TSEM, YSS, RGC, and OKTA.

Avi Kapoor

Top 3 Health Care Stocks That May Keep You Up At Night In June

Health care stocks flashing warning to momentum investors. RSI indicator shows overbought for DFTX, NRIX, GALT. Check BZ Edge Rankings for more.

Avi Kapoor

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the release of fourth-quarter results.

Avi Kapoor

Dow Surges Over 600 Points, Gold Jumps 1.5%

Avi Kapoor

Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.89M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

15.39M

Free Cash Flow (TTM)

-15.89M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-502.00K

Analyst Trends and Forecast

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$520.01M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-11.03%

Earnings Yield % (FWD)

-5.90%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.38

Company Debt

Total Debt

$137.70M

LT Debt

-

LT Debt Issuance (TTM)

$10.00M

LT Debt Repayment (TTM)

-

Total Cash

$13.27M

Debt to Equity

-

Issuance of Debt (TTM)

$10.00M

Repayment of Debt (TTM)

-